Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn’s disease

@article{Bogowski2011NodularRL,
  title={Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn’s disease},
  author={W. Błogowski and W. Marlicz and A. Smereczyński and M. Ławniczak and Agnieszka Lewosiuk and T. Starzynska},
  journal={Immunopharmacology and Immunotoxicology},
  year={2011},
  volume={33},
  pages={398 - 402}
}
Nodular regenerative liver hyperplasia (NRH) is a very rare but potentially severe complication of thiopurine-containing immunosuppressive therapy for autoimmune disorders, organ transplantation, and/or oncological treatment. Here we report a case of a 40-year-old female patient with Crohn’s disease and genetic hypercoagulability disorder—factor V Leiden, who in the course of azathioprine immunosuppressive treatment for inflammatory bowel disease developed NRH, which was clinically manifested… Expand
Nodular Regenerative Hyperplasia: A Rare Complication of Treatment with Thiopurines in Patients with Crohn’s Disease
A 25-year-old male with ileal pre-anastomotic recurrence of Crohn's disease (CD) experienced nodular regenerative hyperplasia (NRH) secondary to treatment with azathioprine (AZA). The subject showedExpand
Clinical and histologic features of Azathioprine-induced hepatotoxicity
TLDR
Hepatotoxicity is relative uncommon in patients receiving Azathioprine, and predominantly is mixed hepatocellular and cholestatic in nature, and even though all patients recover fully after drug withdrawal, severeCholestasis can occur. Expand
Nodular Regenerative Hyperplasia of the Liver: A Rare Vascular Complication in Systemic Sclerosis
TLDR
Investigation of nodular regenerative hyperplasia as a vascular complication of systemic sclerosis with microvasculopathy as a common denominator found it might represent a rare yet potentially life-threatening vascular complication in SSc. Expand
Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology Committees.
TLDR
A clinical summary of some of the major hepatic issues that may occur in patients with IBD is provided as a clinical summary. Expand
Bose T
Autoimmune hepatitis is a rare autoimmune disorder. The regular treatments for this disease is the administration of regular immunosuppressants like Azathiorpine, Metabolic Mycophenolic Acid inExpand
Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy
  • C. Musumba
  • Medicine
  • Alimentary pharmacology & therapeutics
  • 2013
Nodular regenerative hyperplasia (NRH) is increasingly being recognised in patients with inflammatory bowel disease (IBD). However, the pathogenesis and incidence of NRH in IBD, and the putativeExpand
Clinical significance of endoscopic findings in the upper gastrointestinal tract in Crohn’s disease
TLDR
A review summarizes the literature, as well as the own observations and considerations, concerning the issue of upper gastrointestinal involvement in Crohn’s disease and its clinical meaning. Expand
What makes non-cirrhotic portal hypertension a common disease in India? Analysis for environmental factors
TLDR
Environmental factors linked to suboptimal hygiene and sanitation, which enter through the gastrointestinal (GI) tract, predispose to platelet plugging onto activated endothelium in portal microcirculation, is a disease mainly affecting the lower socio-economic strata of Indian population. Expand
Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs
Abstract The Side Effects of Drugs Annuals is a series of volumes in which the adverse effects of drugs and adverse reactions to them are surveyed. The series supplements the contents of Meyler'sExpand
...
1
2
...

References

SHOWING 1-10 OF 35 REFERENCES
Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
TLDR
It is suggested that male patients with small bowel resection ≥50 cm constitute the group with the higher risk of developing NRH while treated with AZA, and the risk of developed NRH during AZA treatment is low. Expand
Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia
TLDR
The association between thiopurine use, NRH and sinusoidal dilatation may be weaker than as reported in recent literature, as there is relatively high background prevalence in selected series. Expand
Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy.
TLDR
The importance of further safety studies to evaluate the aetiology and prevalence of NRH in IBD patients before general conclusions on the use of thiopurines can be drawn is strengthened. Expand
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
TLDR
NRH is a rare but potentially severe complication of azathioprine in patients with inflammatory bowel disease and Clinicians should be aware of this complication, and should monitor liver function tests and platelet counts closely in their patients. Expand
Nodular regenerative hyperplasia and thiopurines: The case for level‐dependent toxicity
  • N. D. de Boer, C. Mulder, A. V. van Bodegraven
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2005
TLDR
Low-dose 6- TG (0.3 mg/kg) is considered as a therapeutic alternative, but until more long-term toxicity data are available, 6-TG use should preferably be restricted to trials with a regular performance of liver biopsies. Expand
Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
  • N. D. de Boer, P. Zondervan, +7 authors C. Mulder
  • Medicine
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2008
TLDR
It is demonstrated that low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients is not likely to be associated with induction of nodular regenerative hyperplasia. Expand
Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation
  • D. Breen, A. Marinaki, M. Arenas, P. Hayes
  • Medicine
  • Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2005
TLDR
It is suggested that TPMT, ITPA, and MTHFR genotypes do not predict adverse drug reactions, including bone marrow suppression, in liver transplant patients, and the possible association between NRH and a heterozygous T PMT genotype should be investigated further. Expand
Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases.
TLDR
The authors report 24 cases of diffuse nodular regenerative hyperplasia of the liver seen in a General Hospital during the last 9 years, suggesting that DNHR is probably more frequent than suspected and could be a preneoplastic condition. Expand
Nodular regenerative hyperplasia and severe portal hypertension in cystinosis.
  • Kevin O'Brien, N. Hussain, +5 authors W. Gahl
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2006
TLDR
NHR was confirmed by histologic examination of the liver in both patients and is the likely cause of their portal hypertension, suggesting NRH may represent a rare, late complication of cystinosis, although the mechanism remains undefined. Expand
Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation
TLDR
After the failure of medical management in patients with nodular regenerative hyperplasia, portosystemic shunting may be indicated before proceeding to hepatic transplantation. Expand
...
1
2
3
4
...